A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers

Clinical trial NCT06082323 · RECRUITING

Trial details

NCT number: NCT06082323
Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Hidradenitis Suppurativa Atopic Dermatitis

Start date: 2024-06-13
Primary completion: 2025-03-31
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.